Sandrine Mores

Company: EXO Biologics

Job title: COO

Bio:

Sandrine Mores, is Chief Operating Officer at ExoBiologics. Since joining as Head of Quality in 2021, Sandrine led the set-up of the GMP manufacturing site of ExoXpert, in parallel to supporting ExoBiologics in obtaining the first authorisation in the world by EMA to start a clinical trial in Europe with MSC derived exosomes. With 22 years of extensive experience in the GMP environment across renowned biotech firms like Eurogentec, Novasep (now Thermo Fisher Scientific), and MasTherCell (now Catalent Cell & Gene Therapy), Sandrine’s journey began in Quality Control, before evolving into Strategic Quality and Operation roles.

Seminars:

Accelerating Exosome-Based Therapeutics: From Innovation to GMP-Ready Solution 9:00 am

Showcasing an update on EXO Biologics’ clinical trials Presenting exosomes use as a safer alternative to viral drug delivery systems Ensuring the quality and compliance of your exosomes NEW DATA!Read more

day: Conference Day One